PM
Prashant Madhav Kate
About Prashant Madhav Kate
Data last updated:
Prashant Madhav Kate has 6 years in corporate governance. Holds Director role. Currently with 1 company, including Fisher & Paykel Healthcare India Private Limited. Engaged in Healthcare. Contributes to corporate operations. The largest current company by reported revenue is Fisher & Paykel Healthcare India Private Limited at ₹165 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Fisher & Paykel Healthcare India Private Limited U51507KA2008FTC047061 | Director | 17 Jan 2020 | 2008 | ₹165 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Prashant Madhav Kate
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prashant Madhav Kate
Prashant Madhav Kate has 6 years in corporate governance. Holds Director role. Currently with 1 company, including Fisher & Paykel Healthcare India Private Limited. Engaged in Healthcare. Contributes to corporate operations. The largest current company by reported revenue is Fisher & Paykel Healthcare India Private Limited at ₹165 Cr (FY 2025).
Prashant Madhav Kate is associated with 1 company as Director, including Fisher & Paykel Healthcare India Private Limited (₹165 Cr).
Prashant Madhav Kate has expertise in Healthcare.
Prashant Madhav Kate has 6 years in corporate governance.
By reported revenue, the largest current company of Prashant Madhav Kate is Fisher & Paykel Healthcare India Private Limited, with revenue of ₹165 Cr (FY 2025).
Prashant Madhav Kate currently holds positions at 1 company: Fisher & Paykel Healthcare India Private Limited (₹165 Cr).